Solanum incanum extract (also known as SR-T100) has been shown to downregulate c/EBPβ and COL11A1 expression, thereby sensitizing melanoma and ovarian cancer cells to cisplatin (90, 91). The gene discussed is COL11A1; the disease is ovarian carcinoma.